A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease
A major contributor to treatment failure in Chagas disease, caused by infection with the protozoan parasite , is that current treatment regimens do not address the drug insensitivity of transiently dormant amastigotes. Here, we demonstrated that use of a currently available drug in a modified treatm...
Saved in:
Published in | Science translational medicine Vol. 12; no. 567 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
28.10.2020
|
Online Access | Get more information |
Cover
Loading…
Abstract | A major contributor to treatment failure in Chagas disease, caused by infection with the protozoan parasite
, is that current treatment regimens do not address the drug insensitivity of transiently dormant
amastigotes. Here, we demonstrated that use of a currently available drug in a modified treatment regimen of higher individual doses, given less frequently over an extended treatment period, could consistently extinguish
infection in three mouse models of Chagas disease. Once per week administration of benznidazole at a dose 2.5 to 5 times the standard daily dose rapidly eliminated actively replicating parasites and ultimately eradicated the residual, transiently dormant parasite population in mice. This outcome was initially confirmed in "difficult to cure" mouse infection models using immunological, parasitological, and molecular biological approaches and ultimately corroborated by whole organ analysis of optically clarified tissues using light sheet fluorescence microscopy (LSFM). This tool was effective for monitoring pathogen load in intact organs, including detection of individual dormant parasites, and for assessing treatment outcomes. LSFM-based analysis also suggested that dormant amastigotes of
may not be fully resistant to trypanocidal compounds such as benznidazole. Collectively, these studies provide important information on the phenomenon of dormancy in
infection in mice, demonstrate methods to therapeutically override dormancy using a currently available drug, and provide methods to monitor alternative therapeutic approaches for this, and possibly other, low-density infectious agents. |
---|---|
AbstractList | A major contributor to treatment failure in Chagas disease, caused by infection with the protozoan parasite
, is that current treatment regimens do not address the drug insensitivity of transiently dormant
amastigotes. Here, we demonstrated that use of a currently available drug in a modified treatment regimen of higher individual doses, given less frequently over an extended treatment period, could consistently extinguish
infection in three mouse models of Chagas disease. Once per week administration of benznidazole at a dose 2.5 to 5 times the standard daily dose rapidly eliminated actively replicating parasites and ultimately eradicated the residual, transiently dormant parasite population in mice. This outcome was initially confirmed in "difficult to cure" mouse infection models using immunological, parasitological, and molecular biological approaches and ultimately corroborated by whole organ analysis of optically clarified tissues using light sheet fluorescence microscopy (LSFM). This tool was effective for monitoring pathogen load in intact organs, including detection of individual dormant parasites, and for assessing treatment outcomes. LSFM-based analysis also suggested that dormant amastigotes of
may not be fully resistant to trypanocidal compounds such as benznidazole. Collectively, these studies provide important information on the phenomenon of dormancy in
infection in mice, demonstrate methods to therapeutically override dormancy using a currently available drug, and provide methods to monitor alternative therapeutic approaches for this, and possibly other, low-density infectious agents. |
Author | Padilla, Angel M Sanchez-Valdez, Fernando White, Brooke Wang, Wei Tarleton, Rick L Bustamante, Juan M |
Author_xml | – sequence: 1 givenname: Juan M orcidid: 0000-0003-2902-7111 surname: Bustamante fullname: Bustamante, Juan M organization: Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA – sequence: 2 givenname: Fernando orcidid: 0000-0002-0045-0453 surname: Sanchez-Valdez fullname: Sanchez-Valdez, Fernando organization: Instituto de Patología Experimental, Universidad Nacional de Salta-CONICET, Salta, Argentina – sequence: 3 givenname: Angel M orcidid: 0000-0002-7907-5667 surname: Padilla fullname: Padilla, Angel M organization: Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA – sequence: 4 givenname: Brooke orcidid: 0000-0002-0441-1355 surname: White fullname: White, Brooke organization: Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA – sequence: 5 givenname: Wei orcidid: 0000-0001-7111-4687 surname: Wang fullname: Wang, Wei organization: Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA – sequence: 6 givenname: Rick L orcidid: 0000-0002-9589-5243 surname: Tarleton fullname: Tarleton, Rick L email: tarleton@uga.edu organization: Department of Cellular Biology, University of Georgia, Athens, Georgia, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33115952$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kM1KxDAUhYMozo--gUheoGOTpjfJchj8gwE3uh5vmtsx0qZD0grz9o6oq7P4OB-cs2DncYjE2I0oV0JIuMtNGBPG3PXkV-ichhrO2FxYBQVIJWdskfNnWYKparhks6oSora1nLP3Ne8HH9pAnvs07Xmifegp8qYjTJljM4Yv4hhPeEg9xpGP6XjAOOShp8xDPPWnTD8W6jIfWr75wD1m7kMmzHTFLlrsMl3_5ZK9Pdy_bp6K7cvj82a9LRpVwViYUhvpjLWorFXoa11VVinQvmrRmJZA1qYE17RaaS2UkiDAKemU0SWAlkt2--s9TO70wu6QQo_puPufKr8BzhxYzQ |
CitedBy_id | crossref_primary_10_1016_j_cvsm_2022_06_008 crossref_primary_10_1016_j_exppara_2023_108490 crossref_primary_10_1371_journal_pntd_0010688 crossref_primary_10_1038_s41564_022_01211_y crossref_primary_10_1016_j_actatropica_2022_106334 crossref_primary_10_1080_13543784_2024_2349289 crossref_primary_10_1038_s41579_022_00777_y crossref_primary_10_1093_jac_dkab054 crossref_primary_10_1128_msphere_00601_22 crossref_primary_10_1590_0074_02760220004 crossref_primary_10_4049_jimmunol_2300373 crossref_primary_10_1016_j_ejmech_2021_113646 crossref_primary_10_1016_j_pt_2023_03_015 crossref_primary_10_1371_journal_ppat_1011627 crossref_primary_10_1080_14786419_2023_2187793 crossref_primary_10_1080_17460441_2024_2349155 crossref_primary_10_1128_aac_00132_23 crossref_primary_10_1111_jvim_17028 crossref_primary_10_3389_fimmu_2024_1342431 crossref_primary_10_1128_AAC_01535_21 crossref_primary_10_2147_JEP_S267378 crossref_primary_10_1186_s13071_021_05040_6 crossref_primary_10_1126_scitranslmed_abg0485 crossref_primary_10_4049_jimmunol_2200723 crossref_primary_10_1016_j_micinf_2023_105240 crossref_primary_10_3390_pathogens10060729 crossref_primary_10_1002_jobm_202300389 crossref_primary_10_1021_acsomega_1c05560 |
ContentType | Journal Article |
Copyright | Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
Copyright_xml | – notice: Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
DBID | NPM |
DOI | 10.1126/scitranslmed.abb7656 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1946-6242 |
ExternalDocumentID | 33115952 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R21 AI142469 – fundername: NIAID NIH HHS grantid: R21 AI108265 – fundername: NIAID NIH HHS grantid: R01 AI151148 – fundername: NIAID NIH HHS grantid: R01 AI124692 |
GroupedDBID | --- 0R~ 4.4 53G 7~K ABJNI ACGFS AENEX AJGZS AJWWR ALMA_UNASSIGNED_HOLDINGS BKF C45 DU5 EBS EMOBN F5P HZ~ NPM O9- OFXIZ OVD OVIDX P2P RHI TEORI |
ID | FETCH-LOGICAL-c436t-80782b899a4994ad573394467d3fa88fe625806bcf74771442616b42b48706672 |
IngestDate | Thu May 23 23:43:42 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 567 |
Language | English |
License | Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c436t-80782b899a4994ad573394467d3fa88fe625806bcf74771442616b42b48706672 |
ORCID | 0000-0003-2902-7111 0000-0002-7907-5667 0000-0002-0441-1355 0000-0001-7111-4687 0000-0002-9589-5243 0000-0002-0045-0453 |
OpenAccessLink | https://ri.conicet.gov.ar/bitstream/11336/141920/5/CONICET_Digital_Nro.f7d3081f-500c-433c-a984-a64583597a9f_B.pdf |
PMID | 33115952 |
ParticipantIDs | pubmed_primary_33115952 |
PublicationCentury | 2000 |
PublicationDate | 2020-10-28 |
PublicationDateYYYYMMDD | 2020-10-28 |
PublicationDate_xml | – month: 10 year: 2020 text: 2020-10-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Science translational medicine |
PublicationTitleAlternate | Sci Transl Med |
PublicationYear | 2020 |
SSID | ssj0068356 |
Score | 2.5006826 |
Snippet | A major contributor to treatment failure in Chagas disease, caused by infection with the protozoan parasite
, is that current treatment regimens do not address... |
SourceID | pubmed |
SourceType | Index Database |
Title | A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33115952 |
Volume | 12 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF6FIiEuqKWl9IX20FtkBPZmvT6mVStUCU6AuNF9pkjERolTCX4Gv5gZzzpxCK1oL5bllZzY83l2nt8w9llZlWaFSZNQCJcIceCQAzJLDNJ9Cj3I8oYy__hEHp2JHxeDi17vvlO1NKvNvr17sq_kf6QK10Cu2CX7D5Kd3xQuwDnIF44gYTg-S8ZDHGRzFdCKdJPZqI9TFsa-7FucBTFteDJ-U3rANc0Bdb-e3MLnX02rcVOI1UfH39M4nClVZuiRni6lbaLl2iqBGje36zaEuJKax34s_CUKzc8wFTQP4gDAfvm75Fxfx7h1DGJXizyWwyFIVGg5wprbxZ4R5_h9mSBHaDdWAY4pKPnY--1JvxZCJtiSsqSA0w7QBjSdY1Wzt7Mo6THh8fa1MbkkWvKOsG_GjbQzpBEqiB3376uP-LbbpTW2livUmScY_6G9XYK9KmMDZmy9Wvk7m2yjvcUjV6UxWU5fsq3oa_AhAecV6_lym20cR5G9Zj-HvMUPR_zwiB9O-OGEHw4S4hE_vIsfflXyBj-c8MOrwAk_POLnDTv7_u3061ESJ24kVmSyRmZqlRpwwTU4wkI7JMssBOylLgtaqeDBW1YH0tgAXmgOvjj439KI1AhMl8s83WEvyqr0u4wHsByt8q6wBnPr1gibey-sOwy6cAP1jr2ld3N5Q7Qql-1be__HlQ9sc4Gqj2w9wHfsP4FRWJu9Rk4PeLlmZA |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+modified+drug+regimen+clears+active+and+dormant+trypanosomes+in+mouse+models+of+Chagas+disease&rft.jtitle=Science+translational+medicine&rft.au=Bustamante%2C+Juan+M&rft.au=Sanchez-Valdez%2C+Fernando&rft.au=Padilla%2C+Angel+M&rft.au=White%2C+Brooke&rft.date=2020-10-28&rft.eissn=1946-6242&rft.volume=12&rft.issue=567&rft_id=info:doi/10.1126%2Fscitranslmed.abb7656&rft_id=info%3Apmid%2F33115952&rft_id=info%3Apmid%2F33115952&rft.externalDocID=33115952 |